A US-based KOL gives an in-depth analysis of current MDS treatment guidelines and considerations in disease diagnosis. This interview also covers the prospective impact of therapies in the clinical trial pipeline and unmet needs within the indication.

This interview was conducted on 20 August, 2025.

If you are a Datamonitor Healthcare client, you may access the interview from our KOL Insight channel.

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal.

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900.